EP Patent

EP0314863A2 — Use of ICAM-1 or its functional derivatives for the treatment of non-specific inflammation

Assigned to Baylor College of Medicine · Expires 1989-05-10 · 37y expired

What this patent protects

The invention provides a method for treating inflammation caused by the non-specific defense system of a mammalian subject. Inflammation is treated by providing the subject with an anti-inflammatory agent capable of inhibiting granulocyte-endothelial cell adhesion.

USPTO Abstract

The invention provides a method for treating inflammation caused by the non-specific defense system of a mammalian subject. Inflammation is treated by providing the subject with an anti-inflammatory agent capable of inhibiting granulocyte-endothelial cell adhesion.

Drugs covered by this patent

Patent Metadata

Patent number
EP0314863A2
Jurisdiction
EP
Classification
—
Expires
1989-05-10
Drug substance claim
No
Drug product claim
No
Assignee
Baylor College of Medicine
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.